🔎 Trials Near Me

Akèy › Kasinom Selil Transizyonèl (Urotelyal) › Ohio › Cleveland

Etid klinik pou Kasinom Selil Transizyonèl (Urotelyal) nan Cleveland, OH

8 etid pou Kasinom Selil Transizyonèl (Urotelyal) ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Ap rekriteFaz 1
  • Exelixis Clinical Site #10, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483

Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma

Ap rekrite
  • University Hospitals Cleveland Medical Center, Urology Institute, Case Comprehensive Cancer Center, Cleveland
  • Cleveland Clinic Glickman Urological and Kidney Institute, Cleveland
Laj 19 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06262516

A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)

Ap rekriteFaz 1/2
  • Cleveland Clinic-Taussig Cancer Center ( Site 1036), Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05562830

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Ap rekriteFaz 1/2
  • University Hospitals Cleveland Medical Center, Cleveland
  • Cleveland Clinic Foundation, Cleveland
  • Cleveland Clinic Taussig Cancer Center Investigational Pharmacy, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07421700

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Ap rekriteFaz 1
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06966024

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Ap rekriteFaz 2
  • University Hospitals Cleveland Medical Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT04879329

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Ap rekriteFaz 3
  • Research Site, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07720284

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Kasinom Selil Transizyonèl (Urotelyal) nan lòt vil

Lòt etid nan Cleveland

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.